Analysis of risk factors of involvement of seminal vesicles in patients with prostate cancer undergoing radical prostatectomy

International Braz J Urol

Volumn 30, Issue 6, 2004, Pages 472-478

  Dall'Oglio, Marcos F ^a,b   Sant'Anna, Alexandre C ^a   Antunes, Alberto A ^a   Nesrallah, Luciano J ^a   Leite, Katia R ^a   Srougi, Miguel ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Rua Barata Ribeiro   (Brazil)

Author keywords

Biopsy; Neoplasm staging; Prostate specific antigen; Prostatic neoplasms; Seminal vesicle

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER INVASION; CONTROLLED STUDY; CORRELATION ANALYSIS; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATIENT SELECTION; PREOPERATIVE EVALUATION; PROBABILITY; PROGNOSIS; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATECTOMY; RATING SCALE; RISK ASSESSMENT; RISK FACTOR; SEMINAL VESICLE DISEASE; TUMOR BIOPSY; TUMOR LOCALIZATION;

EID: 12744260422     PISSN: 16775538     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1677-55382004000600004     Document Type: Article

References (13)

1. Cooperberg MR, Broering JM, Latini DM, Litwin MS, Wallace KL, Carroll PR: Patterns of practice in the United States: insights from PCaSURE on prostate cancer management. Curr Urol Rep. 2004; 5: 166-72.
2. Hull GW, Rabbani F, Abbas F, Wheeler TM, Kattan MW, Scardino PT: Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol. 2002; 7: 528-34.
3. Koh H, Kattan MW, Scardino PT, Suyama K, Maru N, Slawin K, et al.: A nomogram to predict seminal vesicle invasion by the extent and location of cancer in systematic biopsy results. J Urol. 2003; 170: 1203-8.
4. Sofer M, Savoie M, Kim SS, Civantos F, Soloway MS: Biochemical and pathological predictors of the recurrence of prostatic adenocarcinoma with seminal vesicle invasion. J Urol. 2003; 169: 153-6.
5. Zlotta AR, Roumeguere T, Ravery V, Hoffmann P, Montorsi F, Turkeri L, et al.: Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients. Eur Urol. 2004; 46: 42-9.
6. Young HH: The early diagnosis and radical cure of carcinoma of the prostate. Being a study of 40 cases and presentation of a radical operation which was carried out in four cases. 1905. J Urol. 2002; 167: 93946; discussion 947.
7. Partin AW, Mangold LA, Lamm DM, Walsh PC, Epstein JI, Pearson JD: Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology. 2001; 58: 843-8.
8. John H, Hauri D: Seminal vesicle-sparing radical prostatectomy: a novel concept to restore early urinary continence. Urology. 2000; 55: 820-4.
9. Sanda MG, Dunn R, Wei J: Seminal vesicle sparing technique is associated with improved sexual HRQOL outcome after radical prostatectomy. J Urol. 2002; 167: 151, A606.
10. Steiner MS, Morton RA, Walsh PC: Impact of anatomical radical prostatectomy on urinary continence. J Urol. 1991; 145: 512-4; discussion 514-5.
11. Korman HJ, Watson RB, Civantos F, Block NL, Soloway MS: Radical prostatectomy: is complete resection of the seminal vesicles really necessary? J Urol. 1996; 156: 1081-3.
12. Lotan Y, Shariat SF, Khoddami SM, Saboorian H, Koeneman KS, Cadeddu JA, et al.: The percent of biopsy cores positive for cancer is a predictor of advanced pathological stage and poor clinical outcomes in patients treated with radical prostatectomy. J Urol. 2004; 171: 2209-14.
13. Peller PA, Young DC, Marmaduke DP, Marsh WL, Badalament RA: Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens. Cancer. 1995; 75: 530-8.